| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-315 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-315 |
| filingDate |
1985-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67833f7bb685c5170dfdeb7dc0fe6f53 |
| publicationDate |
1987-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4658044-A |
| titleOfInvention |
Intermediates for uracil derivatives |
| abstract |
Compounds of formula (C) <IMAGE> (C) where either RD represents a hydroxymethyl group and RE represents a hydroxyl group or RD represents a protected hydroxymethyl group and RE represents a protected hydroxyl group or RE represents a hydroxyl group and RD represents an ethenyl group and RF represents a hydroxyl or protected hydroxyl group or a leaving group with the proviso that either RD represents a protected hydroxymethyl group and RE represents a protected hydroxyl group or RF represents a protected hydroxyl group, which compounds are of use as intermediates in the preparation of compounds having antiviral activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5874578-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5880304-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5608064-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010099573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5789503-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9115447-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5708115-A |
| priorityDate |
1983-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |